Keros Therapeutics
KROS
KROS
138 hedge funds and large institutions have $480M invested in Keros Therapeutics in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 34 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
138
Holders Change
-18
Holders Change %
-11.54%
% of All Funds
1.85%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
26
Increased
59
Reduced
34
Closed
43
Calls
$13.3M
Puts
$16.4M
Net Calls
-$3.07M
Net Calls Change
+$1.47M
Top Buyers
Top Sellers
| 1 |
NL
Nuveen LLC
Charlotte,
North Carolina
|
$1.01M |
| 2 |
JPMorgan Chase & Co
New York
|
$636K |
| 3 |
Morgan Stanley
New York
|
$11.7M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$8.73M |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VCM
176
Versant Capital Management
Phoenix,
Arizona
| – | -$6.55K | -643 | Closed |
|
|
CCM
177
Coldstream Capital Management
Bellevue,
Washington
| – | -$5.32K | -522 | Closed |
|
|
PTC
178
Private Trust Company
Cleveland,
Ohio
| – | -$825 | -81 | Closed |
|
179
Point72 Asset Management
Stamford,
Connecticut
| – | -$59 | -6 | Closed |
|